Inaccurate medications kill five times more people than road accidents do in developed countries. In France alone, this costs 10 billion euros to the public health system. Around the globe, consolidated numbers are not easily accessible but it is estimated that inaccurate medications cause at least one million deaths and costs 1000 billion dollars to public health systems every year.
ExactCure is a pioneering startup offering a software solution to reduce the impact of inaccurate medication. Their vision is to live in a world where each individual has access to a personalized medicine. Their ambition is to become the world leader in personalized bio-modeling of medicines within 5 years.
Its Digital Twin simulates in silico the efficacy and interactions of medicines in the body of a patient based on his/her personal characteristics. This helps the patient to avoid underdoses, overdoses and drug interactions. Health professionals can potentially follow the patient remotely in real time.
ExactCure’s solutions results from years of fundamental research in bio-modeling with Inria, a tier-1 French fundamental research institute.
ExactCure’s solution is a unique double innovation:
1. Usage Innovation: the patient is empowered because they can predict and visualize the activity of his/her medication.
2. Technological Innovation: Artificial Intelligence simulates the influence of personal characteristics such as age, weight, gender, kidney status, etc. on the effectiveness and interactions of drugs for a given patient. Machine Learning algorithms can also continuously adjust bio-models based on the qualitative feedback of patients.
Goal 3: Good Health and weel-being
ExactCure ensures healthy lives and promote well-being for all at all ages. Their mission is to empower patients by providing them with bio-modeling tools to visualize the effects of drugs within their bodies.
ExactCures sneeds a strong and robust calculation and data management process in order to deliver the best service to patients and health professionals. Their solution leverages proprietary algorithms powered by the 3DEXPERIENCE platform. In particular, its complex workflows will benefit from the BIOVIA Pipeline Pilot backbone.
If a patient shares his/her personalized simulations, health professionals will have the possibility to remotely monitor the effect of drugs in his/her body and receive relevant alerts. This way doctors and pharmacists will have a collaborative tool to improve global health.
Besides, we will build a database allowing a more precise understanding of the influence of drugs on one's body based on individual characteristics. As a consequence, drugs prescriptions will collectively become more accurate and iatrogeny will decrease.
Solidly built upon benevolence and trust, our team also believes that creativity can spur from fun!
Studies estimate the annual number of deaths due to medical errors in the hundreds of thousands, so there is great incentive to revise the way the medical profession gains knowledge and experience. Advances in 3D printing technology and virtual simulation are creating new opportunities to improve the quality of treatments and patient safety.
Have you been in a situation where a generic treatment did not work very well for you or someone you know? Have you ever had that nagging feeling that maybe the doctor (as good as he or she may be) should really be treating YOU rather than a generalized representation of you?
One in 160 children has an autism spectrum disorder according to the United Nations. Children with autism have learning and developmental disorders, and represent a number higher than all others disabilities put together. In the US alone, over 6.4% children have special needs in terms of cognitive, motor and sensory processing skills.
The Living Heart Project aims to advance the development of safe and effective cardiovascular products and treatments by uniting engineering, scientific, and biomedical expertise to translate cutting-edge science into improved patient care. Through simulation and the creation of validated models, the project aims to provide personalized, interventional patient care.
Two 3D experiences, ultra realistic on a scientific point of view, were created through collaborative projects with technologic and scientific partners: "Staying Alive" and "Born To Be Alive".
"Staying Alive" is a serious game that allows to learn appropriate behaviors for first aid techniques.
For patients with chronic illnesses, a primary goal is to create the best possible quality of life for living with a disease. During diagnosis or clinical trials , recording data from patients is often done over a too short a period of time for a proper clinical conclusion.
FEops offers the first and only patient-specific simulation technology for structural heart interventions, surpassing basic anatomical measurement by accurately predicting how devices will interact with each unique patient.
Skin cancer is the most common and fastest growing form of cancer in the world. The main risk factors for developing this type of cancer include exposure to UV radiation, age, sex, ethnicity, occupation, and family history of skin cancer. It is classified in 2 categories : melanoma, the deadliest form, and carcinoma, the most common type.
Do you think your project is the next big thing?
Join the team !